Visugromab

December 9, 2025

BIOT

Discover a new harmonized protocol for assessing mAb charge heterogeneity! 🎉🔬 Optimized methods enhance quality control and reliability. 🌍⚗️📈

May 23, 2025

BIOT

🌟 NIIMBL grants boost biopharmaceutical innovation! 📊 Funding real-time analytics, mAb, and mRNA projects for efficient production. 🚀✨

July 17, 2024

BIOT

💰 German cancer specialist Catalym GmbH raises $150m to fund proof-of-concept studies 🔬💉🧪💼 Exciting progress in solid tumor treatment!